about
Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells.Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineageRas-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)-PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST.Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.Natural variability of minimotifs in 1092 people indicates that minimotifs are targets of evolution.The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma.Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer SusceptibilityDecreased expression of protein tyrosine phosphatase non-receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma.Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration.Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma.MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12.Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST).Clinicopathological significance of PTPN12 expression in human breast cancer.Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complexPTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.
P2860
Q24309666-7E0DB041-4AF8-4B81-9CEF-388BB5D5C4B9Q34085676-D623CDA8-B628-4D24-97F5-B70E1131EEF7Q34208426-A5E83207-A9CA-42A0-8C37-B7BC6CFB7500Q35531397-73933062-11DF-48B3-A853-A45E302AD2B4Q35793909-4B8CAA16-7D24-4BD5-8853-908ECF963C35Q35885933-D8B1482E-8722-40F2-A148-F8239E8AFBB9Q35894633-3390B7F3-DB1B-4C05-A75E-E56B9952DCD3Q35930790-60FE3892-DDE5-49B7-900B-3E15B488F0C2Q35943196-45B017A1-DE1E-4A86-8E89-962B12B5DD23Q36825525-0758D3B5-2CD4-4408-8E67-C4A88A17D36CQ37094958-7FF31197-D98D-4331-BCB0-C75C6DDA4CDFQ37114974-83DFABD9-0318-46D0-BC94-14083A12DBBDQ37354100-BAE9F547-AFEC-4DBA-B88C-E2431106ED14Q37370943-0B46B0F5-5EB8-42CD-AD35-0051F48DF425Q37514154-A2F5FF37-63AF-4812-852A-888AF9603A57Q38444703-116D43E3-8C79-4E2E-9D62-8422CA5CC0F8Q38890318-9806C768-B1F6-4936-B09C-C4E270CED1D1Q39205523-C7A4A3BA-803A-47D5-8381-76A974745BD6Q46679218-F6B78518-9C59-42D0-905F-814FA44AB59AQ49593669-72FA3BA1-DE6C-4805-9B71-30AD3FB8862CQ55262749-BE239E20-CAD9-4BA4-AEF7-6C32B25AB4CF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
PTP-PEST phosphatase variations in human cancer.
@en
type
label
PTP-PEST phosphatase variations in human cancer.
@en
prefLabel
PTP-PEST phosphatase variations in human cancer.
@en
P2093
P1476
PTP-PEST phosphatase variations in human cancer.
@en
P2093
Axel Ullrich
Heinz Hoefler
Jens Ernst Ruhe
Pjotr Knyazev
Stefano Iacobelli
Stephan Peter
Sylvia Streit
Tatjana Knyazeva
P356
10.1016/J.CANCERGENCYTO.2006.05.013
P577
2006-10-01T00:00:00Z